Brigatinib 180mg Tablets $100

Brigatinib is a medication that targets the ALK protein, specifically for people with ALK-positive metastatic NSCLC. It stops the ALK protein from sending signals. You can get it in 30 mg, 90 mg, or 180 mg tablet forms, all with a film coating.

You start with 90 mg a day for a week, then switch to 180 mg every day. It comes in bottles that have 30 tablets each. It’s for treating NSCLC that’s spread around the body and has a positive ALK test.

You take it by mouth to keep the cancer from growing. It does this by keeping the ALK protein, which is usually too active in ALK-positive NSCLC, under control. The tablets are easy to swallow because they’re coated.

And there are three strengths for different dosing schedules. Each bottle has 30 tablets, so it’s easy for patients to get what they need.